Scoping future outbreaks: a scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases.
SARS
geographic information systems
mathematical modelling
systematic review
viral haemorrhagic fevers
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
15
06
2021
accepted:
01
09
2021
entrez:
17
9
2021
pubmed:
18
9
2021
medline:
24
9
2021
Statut:
ppublish
Résumé
The WHO's Research and Development Blueprint priority list designates emerging diseases with the potential to generate public health emergencies for which insufficient preventive solutions exist. The list aims to reduce the time to the availability of resources that can avert public health crises. The current SARS-CoV-2 pandemic illustrates that an effective method of mitigating such crises is the pre-emptive prediction of outbreaks. This scoping review thus aimed to map and identify the evidence available to predict future outbreaks of the Blueprint diseases. We conducted a scoping review of PubMed, Embase and Web of Science related to the evidence predicting future outbreaks of Ebola and Marburg virus, Zika virus, Lassa fever, Nipah and Henipaviral disease, Rift Valley fever, Crimean-Congo haemorrhagic fever, Severe acute respiratory syndrome, Middle East respiratory syndrome and Disease X. Prediction methods, outbreak features predicted and implementation of predictions were evaluated. We conducted a narrative and quantitative evidence synthesis to highlight prediction methods that could be further investigated for the prevention of Blueprint diseases and COVID-19 outbreaks. Out of 3959 articles identified, we included 58 articles based on inclusion criteria. 5 major prediction methods emerged; the most frequent being spatio-temporal risk maps predicting outbreak risk periods and locations through vector and climate data. Stochastic models were predominant. Rift Valley fever was the most predicted disease. Diseases with complex sociocultural factors such as Ebola were often predicted through multifactorial risk-based estimations. 10% of models were implemented by health authorities. No article predicted Disease X outbreaks. Spatiotemporal models for diseases with strong climatic and vectorial components, as in River Valley fever prediction, may currently best reduce the time to the availability of resources. A wide literature gap exists in the prediction of zoonoses with complex sociocultural and ecological dynamics such as Ebola, COVID-19 and especially Disease X.
Sections du résumé
BACKGROUND
The WHO's Research and Development Blueprint priority list designates emerging diseases with the potential to generate public health emergencies for which insufficient preventive solutions exist. The list aims to reduce the time to the availability of resources that can avert public health crises. The current SARS-CoV-2 pandemic illustrates that an effective method of mitigating such crises is the pre-emptive prediction of outbreaks. This scoping review thus aimed to map and identify the evidence available to predict future outbreaks of the Blueprint diseases.
METHODS
We conducted a scoping review of PubMed, Embase and Web of Science related to the evidence predicting future outbreaks of Ebola and Marburg virus, Zika virus, Lassa fever, Nipah and Henipaviral disease, Rift Valley fever, Crimean-Congo haemorrhagic fever, Severe acute respiratory syndrome, Middle East respiratory syndrome and Disease X. Prediction methods, outbreak features predicted and implementation of predictions were evaluated. We conducted a narrative and quantitative evidence synthesis to highlight prediction methods that could be further investigated for the prevention of Blueprint diseases and COVID-19 outbreaks.
RESULTS
Out of 3959 articles identified, we included 58 articles based on inclusion criteria. 5 major prediction methods emerged; the most frequent being spatio-temporal risk maps predicting outbreak risk periods and locations through vector and climate data. Stochastic models were predominant. Rift Valley fever was the most predicted disease. Diseases with complex sociocultural factors such as Ebola were often predicted through multifactorial risk-based estimations. 10% of models were implemented by health authorities. No article predicted Disease X outbreaks.
CONCLUSIONS
Spatiotemporal models for diseases with strong climatic and vectorial components, as in River Valley fever prediction, may currently best reduce the time to the availability of resources. A wide literature gap exists in the prediction of zoonoses with complex sociocultural and ecological dynamics such as Ebola, COVID-19 and especially Disease X.
Identifiants
pubmed: 34531189
pii: bmjgh-2021-006623
doi: 10.1136/bmjgh-2021-006623
pmc: PMC8449939
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
BMC Med. 2007 Nov 21;5:34
pubmed: 18031574
PLoS Negl Trop Dis. 2017 Jul 25;11(7):e0005756
pubmed: 28742814
Res Synth Methods. 2014 Dec;5(4):371-85
pubmed: 26052958
BMC Public Health. 2011 Mar 04;11 Suppl 2:S10
pubmed: 21388561
Asia Pac J Public Health. 2015 Mar;27(2):NP824-32
pubmed: 23343646
Antiviral Res. 2018 Nov;159:63-67
pubmed: 30261226
Philos Trans R Soc Lond B Biol Sci. 2019 Jul 8;374(1776):20180276
pubmed: 31104603
J Infect Dev Ctries. 2014 Jun 11;8(6):749-57
pubmed: 24916874
Philos Trans R Soc Lond B Biol Sci. 2017 Jul 19;372(1725):
pubmed: 28584173
Nature. 2008 Feb 21;451(7181):990-3
pubmed: 18288193
PLoS One. 2016 Mar 01;11(3):e0149988
pubmed: 26930074
N Engl J Med. 2020 May 7;382(19):1832-1842
pubmed: 32441897
Am J Trop Med Hyg. 2010 Aug;83(2 Suppl):43-51
pubmed: 20682905
BMJ. 2003 Nov 29;327(7426):1271-5
pubmed: 14644972
Epidemiol Infect. 2018 Oct;146(13):1625-1627
pubmed: 30056812
Trans R Soc Trop Med Hyg. 2015 Aug;109(8):483-92
pubmed: 26085474
Int J Infect Dis. 2016 May;46:49-55
pubmed: 26996461
Methods Mol Biol. 2009;471:179-95
pubmed: 19109780
Emerg Infect Dis. 2005 Feb;11(2):283-90
pubmed: 15752448
Emerg Infect Dis. 2016 Apr;22(4):723-5
pubmed: 27358972
BMC Infect Dis. 2018 Apr 17;18(1):180
pubmed: 29665783
Cell. 2020 Sep 3;182(5):1077-1092
pubmed: 32846157
PLoS One. 2017 Jan 6;12(1):e0165085
pubmed: 28060809
Ecohealth. 2018 Sep;15(3):497-508
pubmed: 29134435
Int J Infect Dis. 2013 Jul;17(7):e524-8
pubmed: 23474177
Science. 2016 Apr 15;352(6283):345-349
pubmed: 27013429
Lancet. 2017 Dec 16;390(10113):2662-2672
pubmed: 29031848
J Infect. 2017 May;74(5):484-491
pubmed: 28189711
PLoS One. 2016 Jan 25;11(1):e0144570
pubmed: 26808021
Elife. 2014 Sep 08;3:e04395
pubmed: 25201877
PLoS Curr. 2017 Sep 5;9:
pubmed: 29034123
PLoS Negl Trop Dis. 2016 Sep 15;10(9):e0004999
pubmed: 27631374
Infect Ecol Epidemiol. 2015 Jul 31;5:28024
pubmed: 26234531
J R Soc Interface. 2007 Oct 22;4(16):851-63
pubmed: 17580290
J Supercomput. 2016;72(8):3033-3056
pubmed: 32214655
PLoS Negl Trop Dis. 2018 Aug 17;12(8):e0006737
pubmed: 30118497
J Vector Ecol. 2013 Dec;38(2):251-9
pubmed: 24581353
Med Vet Entomol. 1990 Oct;4(4):433-8
pubmed: 1983457
Clin Microbiol Infect. 2020 Jan;26(1):123.e1-123.e7
pubmed: 31129282
Trans R Soc Trop Med Hyg. 2015 Aug;109(8):503-13
pubmed: 26142451
Geospat Health. 2016 May 31;11(2):377
pubmed: 27245792
Public Health. 2017 Feb;143:60-70
pubmed: 28159028
Acta Trop. 2018 Sep;185:391-399
pubmed: 29932934
BMJ Glob Health. 2017 Sep 25;2(3):e000309
pubmed: 29082009
Mem Inst Oswaldo Cruz. 2016 Sep;111(9):559-60
pubmed: 27653360
Lancet. 2012 Dec 1;380(9857):1946-55
pubmed: 23200503
PLoS Negl Trop Dis. 2017 Nov 1;11(11):e0006007
pubmed: 29091713
PLoS Negl Trop Dis. 2009;3(3):e388
pubmed: 19255625
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Lancet. 2012 Dec 1;380(9857):1956-65
pubmed: 23200504
Am J Trop Med Hyg. 2010 Aug;83(2 Suppl):65-72
pubmed: 20682908
Epidemiol Infect. 2015 Mar;143(4):839-50
pubmed: 25703403
Pathog Dis. 2019 Mar 1;77(2):
pubmed: 30985897
BMJ Glob Health. 2021 Aug;6(8):
pubmed: 34429299
Virol Sin. 2020 Jun;35(3):263-265
pubmed: 32060789
Ann Afr Med. 2015 Apr-Jun;14(2):89-96
pubmed: 25693816
Comp Immunol Microbiol Infect Dis. 2020 Apr;69:101429
pubmed: 32062190
PLoS One. 2020 Mar 12;15(3):e0229790
pubmed: 32163439
J Gen Virol. 2019 Aug;100(8):1187-1199
pubmed: 31310198
Sci Rep. 2018 May 22;8(1):7970
pubmed: 29789619
Nature. 2018 Aug;560(7720):573-581
pubmed: 30158602
PLoS Curr. 2014 Nov 24;6:
pubmed: 25685624
Epidemiol Infect. 2010 Feb;138(2):214-25
pubmed: 19580695
Geospat Health. 2007 Nov;2(1):127-35
pubmed: 18686262
Nat Commun. 2019 Feb 22;10(1):898
pubmed: 30796206
Int J Health Geogr. 2006 Dec 28;5:60
pubmed: 17194307
Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15124-9
pubmed: 15477600
Geospat Health. 2016 Mar 31;11(1 Suppl):387
pubmed: 27063733
Cad Saude Publica. 2001;17 Suppl:133-40
pubmed: 11426274
Am J Public Health. 2017 May;107(5):724-731
pubmed: 28323468
Epidemiol Infect. 2018 Aug;146(11):1343-1349
pubmed: 29886854
Infect Dis Model. 2020;5:271-281
pubmed: 32289100
Influenza Other Respir Viruses. 2008 Jul;2(4):139-45
pubmed: 19453466
Emerg Infect Dis. 2016 Dec;22(12):2054-2062
pubmed: 27403563
Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):955-9
pubmed: 19144928
Science. 1999 Jul 16;285(5426):397-400
pubmed: 10411500
BMC Public Health. 2007 May 29;7:93
pubmed: 17535440
J Infect Dev Ctries. 2013 Apr 17;7(4):308-11
pubmed: 23592639
Geospat Health. 2016 Mar 31;11(1 Suppl):394
pubmed: 27063737
Influenza Other Respir Viruses. 2018 Sep;12(5):551-557
pubmed: 29722140
Sci Rep. 2018 Nov 6;8(1):16435
pubmed: 30401870
Clin Microbiol Infect. 2020 Jun;26(6):729-734
pubmed: 32234451
PLoS One. 2016 Oct 27;11(10):e0165383
pubmed: 27788234